The DOI matches its Crossref record; 102 of the 102 references it cites were found in a registry or an index.
Emerging principles in protease-based drug discovery
Open accessAbstract
Proteases have an important role in many signalling pathways, and represent potential drug targets for diseases ranging from cardiovascular disorders to cancer, as well as for combating many parasites and viruses. Although inhibitors of well-established protease targets such as angiotensin-converting enzyme and HIV protease have shown substantial therapeutic success, developing drugs for new protease targets has proved challenging in recent years. This in part could be due to issues such as the difficulty of achieving selectivity when targeting protease active sites. This Perspective discusses the general principles in protease-based drug discovery, highlighting the lessons learned and the emerging strategies, such as targeting allosteric sites, which could help harness the therapeutic potential of new protease targets.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Arzneimittelforschung: Erstanwendung am Menschen in der Phase I
Miletzki, B., & Gleiter, C. H. (2005) · Bundesgesundheitsblatt Gesundheitsforsch.Gesundheitsschutz · doi:10.1007/s00103-005-1024-7 · Cited by 9,355
On the size of the active site in proteases. I. Papain
Schechter, I., & Berger, A. (1967) · Biochemical and Biophysical Research Communications · doi:10.1016/s0006-291x(67)80055-x · Cited by 5,204
Matrix Metalloproteinase Inhibitors and Cancer—Trials and Tribulations
Coussens, L. M., Fingleton, B., & Matrisian, L. M. (2002) · Science · doi:10.1126/science.1067100 · Cited by 2,761
A Combinatorial Approach Defines Specificities of Members of the Caspase Family and Granzyme B
Thornberry, N. A., Rano, T. A., Peterson, E. P., Rasper, D. M., Timkey, T., Garcia-Calvo, M., Houtzager, V. M., Nordstrom, P. A., Roy, S., Vaillancourt, J. P., et al. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.29.17907 · Cited by 2,068
Synthesis and Applications of Small Molecule Libraries
Thompson, L. A., & Ellman, J. A. (1996) · Chemical Reviews · doi:10.1021/cr9402081 · Cited by 1,452
Regulation and cellular roles of ubiquitin-specific deubiquitinating enzymes.
Reyes-Turcu, F. E., Ventii, K. H., & Wilkinson, K. D. (2009) · Annual Review of Biochemistry · doi:10.1146/annurev.biochem.78.082307.091526 · Cited by 1,396
Targeting proteases: successes, failures and future prospects
Turk, B. (2006) · Nature Reviews Drug Discovery · doi:10.1038/nrd2092 · Cited by 1,363
multifunctional enzymes in cancer
Mohamed, M. M., & Sloane, B. F. (2006) · Nature Reviews Cancer · doi:10.1038/nrc1949 · Cited by 1,265
Green, D. R., & Evan, G. I. (2002) · Cancer Cell · doi:10.1016/s1535-6108(02)00024-7 · Cited by 1,254
The Serpins Are an Expanding Superfamily of Structurally Similar but Functionally Diverse Proteins
Silverman, G. A., Bird, P. I., Carrell, R. W., Church, F. C., Coughlin, P. B., Gettins, P. G. W., Irving, J. A., Lomas, D. A., Luke, C. J., Moyer, R. W., et al. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.r100016200 · Cited by 1,230
Self-citationThe apoptosome: Signalling platform of cell death
Riedl, S. J., & Salvesen, G. S. (2007) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm2153 · Cited by 1,097
Self-citationAllosteric modulators of GPCRs: a novel approach for the treatment of CNS disorders
Jeffrey Conn, P., Christopoulos, A., & Lindsley, C. W. (2009) · Nature Reviews Drug Discovery · doi:10.1038/nrd2760 · Cited by 1,063
Biochemistry and Molecular Biology of Gelatinase B or Matrix Metalloproteinase-9 (MMP-9)
Van den Steen, P. E., Dubois, B., Nelissen, I., Rudd, P. M., Dwek, R. A., & Opdenakker, G. (2002) · Critical Reviews in Biochemistry and Molecular Biology · doi:10.1080/10409230290771546 · Cited by 946
The protein structures that shape caspase activity, specificity, activation and inhibition
FUENTES-PRIOR, P., & SALVESEN, G. S. (2004) · Biochemical Journal · doi:10.1042/bj20041142 · Cited by 880
Self-citationKim, D., Wang, L., Beconi, M., Eiermann, G. J., Fisher, M. H., He, H., Hickey, G. J., Kowalchick, J. E., Leiting, B., Lyons, K., et al. (2005) · Journal of Medicinal Chemistry · doi:10.1021/jm0493156 · Cited by 822
Human inhibitor of apoptosis proteins: why XIAP is the black sheep of the family
Eckelman, B. P., Salvesen, G. S., & Scott, F. L. (2006) · The EMBO Reports · doi:10.1038/sj.embor.7400795 · Cited by 813
Self-citationEmerging roles of proteases in tumour suppression
López-Otín, C., & Matrisian, L. M. (2007) · Nature Reviews Cancer · doi:10.1038/nrc2228 · Cited by 802
Cleavage of Cohesin by the CD Clan Protease Separin Triggers Anaphase in Yeast
Uhlmann, F., Wernic, D., Poupart, M.-A., Koonin, E. V., & Nasmyth, K. (2000) · Cell · doi:10.1016/s0092-8674(00)00130-6 · Cited by 798
Matrix metalloproteinase inhibitors as therapy for inflammatory and vascular diseases
Hu, J., Van den Steen, P. E., Sang, Q.-X. A., & Opdenakker, G. (2007) · Nature Reviews Drug Discovery · doi:10.1038/nrd2308 · Cited by 795
Inflammation Dampened by Gelatinase A Cleavage of Monocyte Chemoattractant Protein-3
McQuibban, G. A., Gong, J.-H., Tam, E. M., McCulloch, C. A. G., Clark-Lewis, I., & Overall, C. M. (2000) · Science · doi:10.1126/science.289.5482.1202 · Cited by 772
The Structure of a Complex of Recombinant Hirudin and Human α-Thrombin
Rydel, T. J., Ravichandran, K. G., Tulinsky, A., Bode, W., Huber, R., Roitsch, C., & Fenton, J. W. (1990) · Science · doi:10.1126/science.2374926 · Cited by 709
Falati, S., Gross, P., Merrill-Skoloff, G., Furie, B. C., & Furie, B. (2002) · Nature Medicine · doi:10.1038/nm782 · Cited by 669
Allosteric regulation and catalysis emerge via a common route
Goodey, N. M., & Benkovic, S. J. (2008) · Nature Chemical Biology · doi:10.1038/nchembio.98 · Cited by 667
Sabeh, F., Shimizu-Hirota, R., & Weiss, S. J. (2009) · Journal of Cell Biology · doi:10.1083/jcb.200807195 · Cited by 658
Development of the Proteasome Inhibitor Velcade™ (Bortezomib)
Adams, J., & Kauffman, M. (2004) · Cancer Investigation · doi:10.1081/cnv-120030218 · Cited by 654
Determination of protease cleavage site motifs using mixture-based oriented peptide libraries
Turk, B. E., Huang, L. L., Piro, E. T., & Cantley, L. C. (2001) · Nature Biotechnology · doi:10.1038/90273 · Cited by 560
Death receptor signal transducers: nodes of coordination in immune signaling networks
Wilson, N. S., Dixit, V., & Ashkenazi, A. (2009) · Nature Immunology · doi:10.1038/ni.1714 · Cited by 559
Harris, J. L., Backes, B. J., Leonetti, F., Mahrus, S., Ellman, J. A., & Craik, C. S. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.140132697 · Cited by 541
MEROPS: the peptidase database
Rawlings, N. D., Morton, F. R., Kok, C. Y., Kong, J., & Barrett, A. J. (2007) · Nucleic Acids Research · doi:10.1093/nar/gkm954 · Cited by 520
Brenke, R., Kozakov, D., Chuang, G.-Y., Beglov, D., Hall, D., Landon, M. R., Mattos, C., & Vajda, S. (2009) · Bioinformatics · doi:10.1093/bioinformatics/btp036 · Cited by 455
Wolf, K., Müller, R., Borgmann, S., Bröcker, E.-B., & Friedl, P. (2003) · Blood · doi:10.1182/blood-2002-12-3791 · Cited by 442
Choe, Y., Leonetti, F., Greenbaum, D. C., Lecaille, F., Bogyo, M., Brömme, D., Ellman, J. A., & Craik, C. S. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m513331200 · Cited by 425
Perspectives on NMR in drug discovery: a technique comes of age
Pellecchia, M., Bertini, I., Cowburn, D., Dalvit, C., Giralt, E., Jahnke, W., James, T. L., Homans, S. W., Kessler, H., Luchinat, C., et al. (2008) · Nature Reviews Drug Discovery · doi:10.1038/nrd2606 · Cited by 414
Small-molecule antagonists of apoptosis suppressor XIAP exhibit broad antitumor activity
Schimmer, A. D., Welsh, K., Pinilla, C., Wang, Z., Krajewska, M., Bonneau, M.-J., Pedersen, I. M., Kitada, S., Scott, F. L., Bailly-Maitre, B., et al. (2004) · Cancer Cell · doi:10.1016/s1535-6108(03)00332-5 · Cited by 411
Self-citationNew insights into the molecular mechanisms of the fibrinolytic system
RIJKEN, D. C., & LIJNEN, H. R. (2009) · Journal of Thrombosis and Haemostasis · doi:10.1111/j.1538-7836.2008.03220.x · Cited by 382
Cauwe, B., Van den Steen, P. E., & Opdenakker, G. (2007) · Critical Reviews in Biochemistry and Molecular Biology · doi:10.1080/10409230701340019 · Cited by 381
Timmer, J. C., & Salvesen, G. S. (2007) · Cell Death & Differentiation · doi:10.1038/sj.cdd.4402059 · Cited by 376
Self-citationBasic Mechanisms in Blood Coagulation
Davie, E. W., & Fujikawa, K. (1975) · Annual Review of Biochemistry · doi:10.1146/annurev.bi.44.070175.004055 · Cited by 373
Selective Inhibition of Matrix Metalloproteinase-14 Blocks Tumor Growth, Invasion, and Angiogenesis
Devy, L., Huang, L., Naa, L., Yanamandra, N., Pieters, H., Frans, N., Chang, E., Tao, Q., Vanhove, M., Lejeune, A., et al. (2009) · Cancer Research · doi:10.1158/0008-5472.can-08-3255 · Cited by 355
Towards third generation matrix metalloproteinase inhibitors for cancer therapy
Overall, C. M., & Kleifeld, O. (2006) · British Journal of Cancer · doi:10.1038/sj.bjc.6603043 · Cited by 340
Substrate Phage: Selection of Protease Substrates by Monovalent Phage Display
Matthews, D. J., & Wells, J. A. (1993) · Science · doi:10.1126/science.8493554 · Cited by 339
Reyes-Turcu, F. E., Horton, J. R., Mullally, J. E., Heroux, A., Cheng, X., & Wilkinson, K. D. (2006) · Cell · doi:10.1016/j.cell.2006.02.038 · Cited by 335
Cysteine cathepsin proteases as pharmacological targets in cancer
Palermo, C., & Joyce, J. A. (2008) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2007.10.011 · Cited by 310
Dipeptidyl Peptidase IV Inhibitors for the Treatment of Diabetes
Weber, A. E. (2004) · Journal of Medicinal Chemistry · doi:10.1021/jm030628v · Cited by 278
Rano, T. A., Timkey, T., Peterson, E. P., Rotonda, J., Nicholson, D. W., Becker, J. W., Chapman, K. T., & Thornberry, N. A. (1997) · Chemistry & Biology · doi:10.1016/s1074-5521(97)90258-1 · Cited by 258
Liu, Y., Lashuel, H. A., Choi, S., Xing, X., Case, A., Ni, J., Yeh, L.-A., Cuny, G. D., Stein, R. L., & Lansbury, P. T. (2003) · Chemistry & Biology · doi:10.1016/j.chembiol.2003.08.010 · Cited by 256
Li, J., Lim, S. P., Beer, D., Patel, V., Wen, D., Tumanut, C., Tully, D. C., Williams, J. A., Jiricek, J., Priestle, J. P., et al. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m500588200 · Cited by 250
Turk, B., Turk, D., & Salvesen, G. (2002) · Current Pharmaceutical Design · doi:10.2174/1381612023394124 · Cited by 247
Self-citationBackes, B. J., Harris, J. L., Leonetti, F., Craik, C. S., & Ellman, J. A. (2000) · Nature Biotechnology · doi:10.1038/72642 · Cited by 242
Discovery of an allosteric site in the caspases
Hardy, J. A., Lam, J., Nguyen, J. T., O'Brien, T., & Wells, J. A. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0404781101 · Cited by 239
Cysteine protease inhibitors as chemotherapy for parasitic infections
McKerrow, J. (1999) · Bioorganic & Medicinal Chemistry · doi:10.1016/s0968-0896(99)00008-5 · Cited by 224
Degradomics: Systems biology of the protease web. Pleiotropic roles of MMPs in cancer
Overall, C. M., & Dean, R. A. (2006) · Cancer and Metastasis Reviews · doi:10.1007/s10555-006-7890-0 · Cited by 218
Structural Basis of Ubiquitin Recognition by the Deubiquitinating Protease USP2
Renatus, M., Parrado, S. G., D'Arcy, A., Eidhoff, U., Gerhartz, B., Hassiepen, U., Pierrat, B., Riedl, R., Vinzenz, D., Worpenberg, S., et al. (2006) · Structure · doi:10.1016/j.str.2006.06.012 · Cited by 213
Aliskiren: the first renin inhibitor for clinical treatment
Jensen, C., Herold, P., & Brunner, H. R. (2008) · Nature Reviews Drug Discovery · doi:10.1038/nrd2550 · Cited by 205
In situ assembly of enzyme inhibitors using extended tethering
Erlanson, D. A., Lam, J. W., Wiesmann, C., Luong, T. N., Simmons, R. L., DeLano, W. L., Choong, I. C., Burdett, M. T., Flanagan, W. M., Lee, D., et al. (2003) · Nature Biotechnology · doi:10.1038/nbt786 · Cited by 203
Thornberry, N., & Weber, A. (2007) · Current Topics in Medicinal Chemistry · doi:10.2174/156802607780091028 · Cited by 202
Recent advances in understanding the molecular basis of group B Streptococcus virulence
Maisey, H. C., Doran, K. S., & Nizet, V. (2008) · Expert Reviews in Molecular Medicine · doi:10.1017/s1462399408000811 · Cited by 199
A Basis for SUMO Protease Specificity Provided by Analysis of Human Senp2 and a Senp2-SUMO Complex
Reverter, D., & Lima, C. D. (2004) · Structure · doi:10.1016/j.str.2004.05.023 · Cited by 198
Catalytic properties and inhibition of proline-specific dipeptidyl peptidases II, IV and VII
LEITING, B., PRYOR, K. D., WU, J. K., MARSILIO, F., PATEL, R. A., CRAIK, C. S., ELLMAN, J. A., CUMMINGS, R. T., & THORNBERRY, N. A. (2003) · Biochemical Journal · doi:10.1042/bj20021643 · Cited by 181
The structural basis for substrate and inhibitor selectivity of the anthrax lethal factor
Turk, B. E., Wong, T. Y., Schwarzenbacher, R., Jarrell, E. T., Leppla, S. H., Collier, R. J., Liddington, R. C., & Cantley, L. C. (2004) · Nature Structural & Molecular Biology · doi:10.1038/nsmb708 · Cited by 179
Dipeptidyl Peptidase-4 Inhibitors for the Treatment of Type 2 Diabetes: Focus On Sitagliptin
Herman, G. A., Stein, P. P., Thornberry, N. A., & Wagner, J. A. (2007) · Clinical Pharmacology & Therapeutics · doi:10.1038/sj.clpt.6100167 · Cited by 166
Bogoyevitch, M. A., & Fairlie, D. P. (2007) · Drug Discovery Today · doi:10.1016/j.drudis.2007.06.008 · Cited by 164
Smith, C. G., & Vane, J. R. (2003) · The FASEB Journal · doi:10.1096/fj.03-0093life · Cited by 161
Multiple Solvent Crystal Structures: Probing Binding Sites, Plasticity and Hydration
Mattos, C., Bellamacina, C. R., Peisach, E., Pereira, A., Vitkup, D., Petsko, G. A., & Ringe, D. (2006) · Journal of Molecular Biology · doi:10.1016/j.jmb.2006.01.039 · Cited by 156
Small Ubiquitin-related Modifier (SUMO)-specific Proteases
Mikolajczyk, J., Drąg, M., Békés, M., Cao, J. T., Ronai, Z. A., & Salvesen, G. S. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m702444200 · Cited by 152
Self-citationStructural and kinetic determinants of protease substrates
Timmer, J. C., Zhu, W., Pop, C., Regan, T. W., Snipas, S. J., Eroshkin, A. M., Riedl, S. J., & Salvesen, G. S. (2009) · Nature Structural & Molecular Biology · doi:10.1038/nsmb.1668 · Cited by 136
Self-citationSchweizer, A., Roschitzki‐Voser, H., Amstutz, P., Briand, C., Gulotti-Georgieva, M., Prenosil, E., Binz, H. K., Capitani, G., Baici, A., Plückthun, A., et al. (2007) · Structure · doi:10.1016/j.str.2007.03.014 · Cited by 133
Identification of a New Class of Nonpeptidic Inhibitors of Cruzain
Brak, K., Doyle, P. S., McKerrow, J. H., & Ellman, J. A. (2008) · Journal of the American Chemical Society · doi:10.1021/ja710254m · Cited by 132
Efficient synthetic inhibitors of anthrax lethal factor
Forino, M., Johnson, S. L., Wong, T. Y., Rozanov, D. V., Savinov, A. Y., Li, W., Fattorusso, R., Becattini, B., Orry, A. J. W., Jung, D., et al. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0502733102 · Cited by 128
Small Molecule-Induced Allosteric Activation of the Vibrio cholerae RTX Cysteine Protease Domain
Lupardus, P. J., Shen, A., Bogyo, M. S., & García, K. C. (2008) · Science · doi:10.1126/science.1162403 · Cited by 121
Wood, W. J. L., Patterson, A. W., Tsuruoka, H., et al. (2005) · Journal of the American Chemical Society · doi:10.1021/ja0547230 · Cited by 114
Troy, C. M., & Salvesen, G. S. (2002) · Journal of Neuroscience Research · doi:10.1002/jnr.10294 · Cited by 112
Self-citationMelnikova, I. (2009) · Nature Reviews Drug Discovery · doi:10.1038/nrd2851 · Cited by 98
Highly active and selective endopeptidases with programmed substrate specificities
Varadarajan, N., Rodriguez, S., Hwang, B., Georgiou, G., & Iverson, B. L. (2008) · Nature Chemical Biology · doi:10.1038/nchembio.80 · Cited by 94
Activation of a protease cascade involved in patterning the Drosophila embryo
LeMosy, E. K., Tan, Y.-Q., & Hashimoto, C. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.081026598 · Cited by 92
The therapeutic potential of a kallikrein inhibitor for treating hereditary angioedema
Levy, J. H., & O’Donnell, P. S. (2006) · Expert Opinion on Investigational Drugs · doi:10.1517/13543784.15.9.1077 · Cited by 87
Inhibition of a viral enzyme by a small-molecule dimer disruptor
Shahian, T., Lee, G., Lazic, A., Arnold, L. A., Velusamy, P., Roels, C. M., Guy, R. K., & Craik, C. S. (2009) · Nature Chemical Biology · doi:10.1038/nchembio.192 · Cited by 80
Role of Factor XII in hemostasis and thrombosis: clinical implications
Renné, T., & Gailani, D. (2007) · Expert Review of Cardiovascular Therapy · doi:10.1586/14779072.5.4.733 · Cited by 75
Selective Activity‐Based Probes for Cysteine Cathepsins
Watzke, A., Kosec, G., Kindermann, M., Jeske, V., Nestler, H. P., Türk, V., Turk, B., & Wendt, K. U. (2007) · Angewandte Chemie International Edition · doi:10.1002/anie.200702811 · Cited by 74
Tumor suppression by a rationally designed reversible inhibitor of methionine aminopeptidase-2.
Wang, J., Sheppard, G. S., Lou, P., Kawai, M., BaMaung, N. Y., Erickson, S., Tucker, L. A., Park, C. Y., Bouska, J. J., Wang, Y.-C., et al. (2003) · PubMed · Cited by 65
Kim, D., Kowalchick, J. E., Brockunier, L. L., Parmee, E. R., Eiermann, G. J., Fisher, M. H., He, H., Leiting, B., Lyons, K. A., Scapin, G., et al. (2008) · Journal of Medicinal Chemistry · doi:10.1021/jm070330v · Cited by 63
Engineering of a macromolecular scaffold to develop specific protease inhibitors
Stoop, A. A., & Craik, C. S. (2003) · Nature Biotechnology · doi:10.1038/nbt860 · Cited by 63
MS‐driven protease substrate degradomics
Impens, F., Colaert, N., Helsens, K., Plasman, K., Damme, P. V., Vandekerckhove, J. S., & Gevaert, K. (2010) · PROTEOMICS · doi:10.1002/pmic.200900418 · Cited by 62
Drąg, M., Mikolajczyk, J., Békés, M., Reyes‐Turcu, F. E., Ellman, J. A., Wilkinson, K. D., & Salvesen, G. S. (2008) · Biochemical Journal · doi:10.1042/bj20080779 · Cited by 61
Self-citationHu, J., den Steen, P. E. V., Dillen, C., & Opdenakker, G. (2005) · Biochemical Pharmacology · doi:10.1016/j.bcp.2005.04.047 · Cited by 55
Maric, S., Donnelly, S., Robinson, M. W., Skinner‐Adams, T. S., Trenholme, K. R., Gardiner, D. L., Dalton, J. P., Stack, C. M., & Lowther, J. (2009) · Biochemistry · doi:10.1021/bi9003638 · Cited by 53
Drąg, M., Mikolajczyk, J., Krishnakumar, I. M., Huang, Z., & Salvesen, G. S. (2007) · Biochemical Journal · doi:10.1042/bj20070940 · Cited by 53
Self-citationHansen, M. A., Wind, T., Blouse, G. E., Christensen, A., Petersen, H. H., Kjelgaard, S., Mathiasen, L., Holtet, T. L., & Andreasen, P. A. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m505933200 · Cited by 52
ADAM Proteins- Therapeutic Potential in Cancer
Lu, X., Lu, D., Scully, M. F., & Kakkar, V. V. (2008) · Current Cancer Drug Targets · doi:10.2174/156800908786733478 · Cited by 46
An Inhibitor Binding Pocket Distinct from the Catalytic Active Site on Human β-APP Cleaving Enzyme
Kornacker, M. G., Lai, Z., Witmer, M. R., Ma, J., Hendrick, J. P., Lee, V. G., Riexinger, D., Mapelli, C., Metzler, W. J., & Copeland, R. A. (2005) · Biochemistry · doi:10.1021/bi050932l · Cited by 45
Activation mechanism and substrate specificity of the Drosophila initiator caspase DRONC
Snipas, S. J., Drąg, M., Stennicke, H. R., & Salvesen, G. S. (2008) · Cell Death and Differentiation · doi:10.1038/cdd.2008.23 · Cited by 42
Self-citationTurk, B. E., Lee, D. H., Yamakoshi, Y., Klingenhoff, A., Reichenberger, E., Wright, J. T., Simmer, J. P., Komisarof, J. A., Cantley, L. C., & Bartlett, J. D. (2006) · Biochemistry · doi:10.1021/bi052252o · Cited by 42
Inhibitors of Tissue Factor • Factor VIIa for Anticoagulant Therapy
Lazarus, R. A., Olivero, A. G., Eigenbrot, C. W., & Kirchhofer, D. (2004) · Current Medicinal Chemistry · doi:10.2174/0929867043364568 · Cited by 42
Positional Scanning Synthetic Combinatorial Libraries for Substrate Profiling
Schneider, E. L., & Craik, C. S. (2009) · Methods in molecular biology · doi:10.1007/978-1-60327-003-8_4 · Cited by 39
The initiating proteases of the complement system: Controlling the cleavage
Duncan, R. C., Wijeyewickrema, L. C., & Pike, R. N. (2007) · Biochimie · doi:10.1016/j.biochi.2007.07.023 · Cited by 39
Imamura, T., Potempa, J., & Travis, J. W. (2004) · Biological Chemistry · doi:10.1515/bc.2004.129 · Cited by 38
Wada, C. K. (2004) · Current Topics in Medicinal Chemistry · doi:10.2174/1568026043388015 · Cited by 29
Düsing, R., & Sellers, F. (2009) · Current Medical Research and Opinion · doi:10.1185/03007990903152045 · Cited by 28
Sureshkumar, K. K. (2008) · Vascular Health and Risk Management · doi:10.2147/vhrm.s3364 · Cited by 22
Methods to measure ubiquitin-dependent proteolysis mediated by the anaphase-promoting complex
Kraft, C., Gmachl, M., & Peters, J. (2005) · Methods · doi:10.1016/j.ymeth.2005.07.005 · Cited by 22
Hu, J., Fiten, P., den Steen, P. E. V., Chaltin, P., & Opdenakker, G. (2005) · Analytical Chemistry · doi:10.1021/ac048631p · Cited by 20
Piccard, H., Hu, J., Fiten, P., Proost, P., Martens, E., den Steen, P. E. V., Damme, J. V., & Opdenakker, G. (2009) · Electrophoresis · doi:10.1002/elps.200800698 · Cited by 12
Cited by
Metal nanoclusters: novel probes for diagnostic and therapeutic applications
Tao, Y., Li, M., Ren, J., & Qu, X. (2015) · Chemical Society Reviews · doi:10.1039/c5cs00607d · Cited by 736
Rut, W., Lv, Z., Zmudzinski, M., Patchett, S., Nayak, D., Snipas, S. J., El Oualid, F., Huang, T. T., Bekes, M., Drag, M., et al. (2020) · Science Advances · doi:10.1126/sciadv.abd4596 · Cited by 459
Self-citationDeubiquitinases in cancer: new functions and therapeutic options
Fraile, J. M., Quesada, V, Rodríguez, D., Freije, J. M. P., & López-Otín, C. (2012) · Oncogene · doi:10.1038/onc.2011.443 · Cited by 453
Feline coronavirus drug inhibits the main protease of SARS-CoV-2 and blocks virus replication
Vuong, W., Khan, M. B., Fischer, C., Arutyunova, E., Lamer, T., Shields, J., Saffran, H. A., McKay, R. T., van Belkum, M. J., Joyce, M. A., et al. (2020) · Nature Communications · doi:10.1038/s41467-020-18096-2 · Cited by 438
Sevenich, L., Bowman, R. L., Mason, S. D., Quail, D. F., Rapaport, F., Elie, B. T., Brogi, E., Brastianos, P. K., Hahn, W. C., Holsinger, L. J., et al. (2014) · Nature Cell Biology · doi:10.1038/ncb3011 · Cited by 382
Metadata
- Authors
- Drag, M., & Salvesen, G. S.
- Venue
- Nature Reviews Drug Discovery
- Published
- 2010-09
- Volume
- 9
- Issue
- 9
- Pages
- 690-701
- ISSN
- 1474-1776 (ISSN-L)
- 1474-1784
- OpenAlex
- W2017871159
- Cited by
- 601
- References
- 102
- FWCI
- 1.70
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.